Cargando…
Long-Lasting Mucosal and Systemic Immunity against Influenza A Virus Is Significantly Prolonged and Protective by Nasal Whole Influenza Immunization with Mucosal Adjuvant N3 and DNA-Plasmid Expressing Flagellin in Aging In- and Outbred Mice
Background: Vaccination is commonly used to prevent and control influenza infection in humans. However, improvements in the ease of delivery and strength of immunogenicity could markedly improve herd immunity. The aim of this pre-clinical study is to test the potential improvements to existing intra...
Autores principales: | Hinkula, Jorma, Nyström, Sanna, Devito, Claudia, Bråve, Andreas, Applequist, Steven E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789645/ https://www.ncbi.nlm.nih.gov/pubmed/31315253 http://dx.doi.org/10.3390/vaccines7030064 |
Ejemplares similares
-
DNA-Encoded Flagellin Activates Toll-Like Receptor 5 (TLR5), Nod-like Receptor Family CARD Domain-Containing Protein 4 (NRLC4), and Acts as an Epidermal, Systemic, and Mucosal-Adjuvant
por: Nyström, Sanna, et al.
Publicado: (2013) -
Endocine™, N3OA and N3OASq; Three Mucosal Adjuvants That Enhance the Immune Response to Nasal Influenza Vaccination
por: Falkeborn, Tina, et al.
Publicado: (2013) -
The intranasal adjuvant Endocine™ enhances both systemic and mucosal immune responses in aged mice immunized with influenza antigen
por: Falkeborn, Tina, et al.
Publicado: (2017) -
Riboflavin as a Mucosal Adjuvant for Nasal Influenza Vaccine
por: Yin, Yinyan, et al.
Publicado: (2021) -
Mucosal Vaccination for Influenza Protection Enhanced by Catalytic Immune‐Adjuvant
por: Qin, Tao, et al.
Publicado: (2020)